Welcome to our dedicated page for Barnwell Inds SEC filings (Ticker: BRN), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
Struggling to track Barnwell Industries’ depletion charges or land-sale gains buried deep in its 10-K? Energy accounting, reserve revisions, and contract drilling margins can stretch past 200 pages, turning routine research into a time sink.
Our platform solves that problem. Stock Titan delivers every Barnwell Industries SEC filing the moment it hits EDGAR—from the annual report 10-K to each quarterly earnings report 10-Q filing and rapid-fire 8-K material events. An AI engine translates dense footnotes into plain language, so you can move from “What does this mean?” to actionable insight in minutes. Want the latest Barnwell Industries insider trading Form 4 transactions? You’ll see Form 4 insider transactions in real time, complete with AI-powered context on executive stock moves.
Use the page to:
- Review Barnwell Industries executive stock transactions Form 4 alongside commodity-price charts.
- Compare production volumes and depletion rates across periods with our Barnwell Industries earnings report filing analysis.
- Dive into the Barnwell Industries proxy statement executive compensation without combing through legal language.
- Get notifications when a new Barnwell Industries 8-K material events explained is posted.
Whether you’re understanding Barnwell Industries SEC documents with AI for the first time or you’re a veteran investor needing quick updates, this page keeps you current, informed, and ahead of the market.
Intellia Therapeutics (NTLA) has filed a Form 4 reporting that Vice President & Chief Accounting Officer Michael P. Dube sold 2,503 shares of common stock on 07/02/2025 at $9.95 per share. The filing states this was a mandatory sell-to-cover transaction to satisfy tax-withholding obligations arising from the vesting of restricted stock units (RSUs) on 07/01/2025, rather than a discretionary sale. After the transaction, Dube continues to hold 57,137 shares directly. No derivative positions were reported.
The dollar value of the sale (≈ $25 k) is immaterial relative to Intellia’s market capitalization and daily trading volume, and the officer retains a meaningful equity stake. As such, investors are likely to view the disclosure as routine housekeeping with neutral implications for the stock’s fundamental outlook.
Sherwood Group, holding approximately 29.9% of Barnwell Industries’ (BRN) shares, filed DFAN14A materials reiterating concerns over the Company’s governance and board composition. The 2025 Annual Meeting has been adjourned a third time, now set for September, leaving only two incumbent directors—Ken Grossman and Josh Horowitz—on a board that may fall short of NYSE independence requirements. Sherwood highlights that more than 45% of shares have already been cast for change via the Green proxy card and discloses preliminary vote counts showing independent support for Messrs. Grossman and Horowitz at just 2.44% and 4.8%, respectively, after excluding insider holdings. Sherwood’s latest settlement proposal seeks a refreshed five-member board retaining Horowitz, adding CEO Craig Hopkins, Green-card nominees Ben Pierson and Heather Isidoro, and former director Brad Tirpak; no seat was requested for Sherwood himself. The group reports that the proposal was ignored but states its willingness to engage further. Shareholders are reminded that votes remain revocable until the rescheduled meeting.